The second consignment of 2.5 million doses of Corona vaccine Covaxin of Hyderabad-based company Bharat Biotech came out of the factory on Friday morning. It will go to 22 cities of the country including Delhi, Mumbai. This is expected to give further momentum to vaccination. Earlier on January 13, the first consignment of 2.4 lakh doses from Bharat Biotech reached 11 cities in the country. Bharat Biotech has received an order of 55 lakh doses from the Central Government. This second consignment is his second installment.
Covaxin of Bharat Biotech as well as Covishield of Serum Institute of India are being used in the vaccination started in India on 16 January.
A source associated with Bharat Biotech told news agency IANS that a second shipment of covaxin has been sent to 22 cities on Friday morning. The vaccine dose will reach its destination by Saturday morning. According to the information so far, 25,66,860 doses in 1,28,343 vials have left from the factory. There are 20 doses in every 10 ml bottle. The vaccine will arrive from Hyderabad to Government Medical Store depots located in Chennai, Karnal, Kolkata, and Mumbai. The indigenous vaccine will reach Ganaavaram, Kurukshetra, Patna, Lucknow, Guwahati, Kolkata Salt Lake, Jaipur, Gandhi Nagar, and Bhopal in Andhra Pradesh. Apart from this, some doses will also go to Delhi, Raipur, Ranchi, Thiruvananthapuram, Chandigarh, Bengaluru, Pune, Bhubaneswar, and Hyderabad.
Covaxin is surrounded by controversies
Covaxin has been mired in controversies ranging from emergency approval to vaccination. The data for phase-3 trials of the vaccine was not revealed and its efficacy is not known. Trials of Phase-1 and Phase-2 reveal their safety and ability to produce immune responses. Many scientists and doctors had spoken of not applying covaxin before the efficacy data came out. Due to this, even doctors in priority groups are seen to be avoiding covaxin.
India's first indigenous corona vaccine
Covaxin is India's first indigenous corona vaccine, developed by Bharat Biotech in association with the Indian Council of Medical Research (ICMR) and the National Institute of Virology (NIV). The inactivated virus vaccine is being developed and manufactured in Bharat Biotech's BSL-3 (Biosafety Level 3) biocontainment facility.
Covishield will leave for Myanmar, Seychelles, and Mauritius
The consignment from Corona Vaccine Covishield's Serum Institute of India (SII) will leave for Myanmar, Seychelles, and Mauritius. It reached Chhatrapati Shivaji Maharaj International Airport in Mumbai on Friday morning. 15 lakh doses of Myanmar, 1 lakh doses of Mauritius, and 50 thousand doses of seashells. Earlier, India's Foreign Ministry had announced to send vaccine doses for Bhutan, Maldives, Bangladesh, Nepal, Myanmar, and Seychelles from Wednesday. This vaccine is being sent based on Neighborhood First Policy ie First Neighbor Policy.
On Wednesday, two days before the public meeting of Prime Minister Narendra Modi in Doda district
'Stop the 10-minute delivery option', Gig workers on strike today; what are their demands?
The countdown to the New Year has begun. In a few hours, the entire world will be celebrating the
OMG 2 Trailer Twitter Reaction: People liked the trailer of Akshay Kumar's film, CBFC got ripped off
OMG, 2 Trailer Twitter Reaction: Akshay Kumar and Pankaj Tripathi's film Oh My God 2 is very clos
The year 2022 is special for India. In January 2022, India will chair the Committee on Counter-Te
In the last 24 hours, 2,745 new corona cases have been reported in the country, and 6 died. At th
National Security Advisor (NSA) Ajit Doval has left for Tajikistan's capital Dushanbe to attend a
A minister of the United Arab Emirates (UAE) has become convinced of the ability of India's Exter
PFI Ban: Ban on PFI to continue, Karnataka High Court dismisses petition challenging the ban
The Karnataka High Court has upheld the ban on the Popular Front of India (PFI). The court on Wed
PM Modi at Vishwa Bharati University - educated people are also involved in spreading terror
PM Modi attended it digitally at the convocation of Visva Bharati University. Union Education Min
Covishield: Covishield can cause blood clots; Vaccine maker AstraZeneca admitted side effects
Vaccine maker AstraZeneca has admitted for the first time in a British court that its COVID-19 va
